AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 128, Issue 8, Pages 1452-1465
Publisher
Springer Science and Business Media LLC
Online
2023-02-17
DOI
10.1038/s41416-022-02127-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis
- (2022) Archita Das et al. NATURE CELL BIOLOGY
- SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
- (2021) Qiwei Jiang et al. Molecular Cancer
- AMPK: restoring metabolic homeostasis over space and time
- (2021) Elijah Trefts et al. MOLECULAR CELL
- Copper Promotes Tumorigenesis by Activating the PDK1‐AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner
- (2021) Jianping Guo et al. Advanced Science
- Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
- (2021) Divya Ramchandani et al. Nature Communications
- Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma
- (2020) Tiffany Tsang et al. NATURE CELL BIOLOGY
- Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions
- (2020) Lavanya Ponnusamy et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate
- (2020) Manuel Rieber CURRENT PHARMACEUTICAL DESIGN
- Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
- (2020) Florida Voli et al. CANCER RESEARCH
- Structural and Functional Diversity Among the Members of CTR, the Membrane Copper Transporter Family
- (2020) Taniya Mandal et al. JOURNAL OF MEMBRANE BIOLOGY
- Serum copper and zinc levels in breast cancer: A meta-analysis
- (2020) Yue Feng et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Metformin and Breast Cancer: Molecular Targets
- (2019) J. Faria et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin in breast cancer: preclinical and clinical evidence
- (2019) Anindita De et al. CURRENT PROBLEMS IN CANCER
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Copper deficiency anemia: review article
- (2018) Zin W. Myint et al. ANNALS OF HEMATOLOGY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A
- (2016) Yuanzhong Wu et al. Cell Discovery
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow
- (2015) Yusuke Saito et al. Cell Stem Cell
- Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
- (2014) Kaniyampadi Snima et al. CURRENT CANCER DRUG TARGETS
- Copper is required for oncogenic BRAF signalling and tumorigenesis
- (2014) Donita C. Brady et al. NATURE
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Repositioning metformin for cancer prevention and treatment
- (2013) Brendan J. Quinn et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Ctr1 Is an Apical Copper Transporter in Mammalian Intestinal Epithelial Cellsin VivoThat Is Controlled at the Level of Protein Stability
- (2010) Yasuhiro Nose et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes
- (2009) Toshiyuki Amano et al. JOURNAL OF NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now